Nat Rev Cardiol (2019) 16(4):20312
By introducing new medications and forming collaborations with different caregivers, weve seen real results people feel better and avoid hospitalizations, said Tony Bashall, MD, an Indianapolis cardiologist at Franciscan Health Indiana Heart Physicians with an interest in cardiometabolic health
While various GLP-1 RAs such as Semaglutide (Wegovy, Ozempic), Dulaglutide (Trulicity), Lixisenatide (Adlyxin), and Tirzepatide (Mounjaro, Zepbound) are commonly prescribed, their specific pharmacokinetics and effects on gastric motility vary, adding complexity to perioperative care (Almandoz et al
Dit heeft negatieve gevolgen voor de lipide huishouding in de lever en ook voor de energievoorziening via vetverbranding in het hart